Table 2.
Characteristics | All N = 310 |
Patients | p | |
---|---|---|---|---|
Low < 9.5 pg/mL N = 164 |
High ≥ 9.5 pg/mL N = 146 |
|||
SBP, cmHg | 13.0 ± 2.2 | 12.8 ± 1.9 | 12.7 ± 2.3 | 0.818 |
DBP, cmHg | 7.4 ± 1.3 | 7.4 ± 1.1 | 7.4 ± 1.5 | 0.750 |
Heart rate, b/min | 75.5 ± 15.7 | 73.9 ± 14.4 | 77.1 ± 17.7 | 0.208 |
Ejection Fraction, % | 49.3 ± 13.7 | 52.9 ± 13.0 | 45.8 ± 13.8 | 0.077 |
Vessel involved, % | ||||
LMCA | 6.9 | 45.5 | 54.5 | 0.581 |
LCx | 48.4 | 53.2 | 46.8 | 0.959 |
IVA | 73.0 | 53.4 | 46.6 | 0.996 |
RCA | 47.2 | 56.0 | 44.0 | 0.544 |
Stenosis, % | 0.723 | |||
[50–70] | 26.9 | 57.1 | 42.9 | |
> 70 | 73.1 | 52.6 | 47.4 | |
Gensini Score categories | 0.022 | |||
Low (GS < 40) | 42.9 | 50.0 | 50.0 | |
High (GS > 40) | 57.1 | 34.3 | 65.7 | |
Vessel Disease, % | 0.344 | |||
One Vessel | 44.7 | 49.3 | 56.8 | |
Multi Vessel | 55.3 | 50.7 | 43.2 | |
Glucose, mmol/L | 7.9 (3.1–42.3) | 8.09 (3.8–21.23) | 7.6 (3.1–41.6) | 0.680 |
HbA1c, % | 7.9 ± 2.4 | 7.9 ± 2.3 | 7.2(5.3–12.7) | 0.630 |
Urae, mmol/L | 5.7 (2.5–30.5) | 5.2 (2.5–12.6) | 5.6 (2.3–30.5) | 0.003 |
Creatinin, µmol/L | 88.0(5–164) | 85(5–148) | 89.5(40–164) | 0.153 |
Uric Acid, µmol/L | 309.0 (82.0–817.0) | 312.0 (217.0–633.0) | 316.0 (126.0–591.0) | 0.051 |
TC, mmol/L | 4.4 ± 1.4 | 4.4 ± 1.4 | 4.3 ± 1.4 | 0.542 |
TG, mmol/L | 1.4 (0.3–12.1) | 1.4 (0.3–12.1) | 1.4 (0.5–4.8) | 0.389 |
HDL-C, mmol/L | 0.9 (0.23–1.9) | 0.9 (0.23–1.83) | 0.8 (0.33–1.9) | 0.802 |
LDL-C, mmol/L | 2.7 (0.4–6.0) | 2.4 (0.4–5.0) | 3.0 (0.6–5.0) | 0.056 |
Lp(a), mg/dL | 11.0 (1.5–123.0) | 10.7 (2.3–123.0) | 10.7 (1.5–110.7) | 0.925 |
ApoA1, mg/dL | 95.9 (0.0–145.0) | 94.05 (0.0–145.0) | 94.05 (20.1–147.0) | 0.466 |
ApoB, mg/dL | 72.2(7.2–152.0) | 70.5(22.0–133.0) | 74.5(7.2–152.0) | 0.120 |
AIP | 0.18(0.58–1.41) | 0.15(0.35–1.41) | 0.19(0.58–0.66) | 0.545 |
ApoB/ApoA1 | 0.8(0.1–5.1) | 0.7(0.2–3.1) | 0.8(0.1–5.1) | 0.075 |
HDLc/ApoA1 | 0.9(0.3–2.4) | 1.0(0.3–2.4) | 0.9(0.5–1.8) | 0.378 |
HDLc/Lp(a) | 7.2(0.7–58.8) | 7.4(0.7–0.9) | 6.5(0.9–41.7) | 0.232 |
Hcy, µmol/L | 18.9(3.7–50.0) | 15.4(7.7–50.0) | 23.5(3.7–50.0) | 0.125 |
HGB, g/dL | 13.2(8.1–17.4) | 13.8(8.8–17.3) | 13.0(8.1–17.4) | 0.019 |
IL-6, pg/mL | 9.0(1.5–3640.0) | 4.6(1.5–9.4) | 24.8(9.6–3640.0) | 0.001 |
hsCRP, mg/L | 4.9(0.2–1020.0) | 3.2(0.2–100.0) | 14.3(0.3–1020.0) | 0.002 |
GS | 53.0 ± 38.7 | 46.7 ± 37.2 | 60.6 ± 39.5 | 0.027 |
AIP Atherogenic index of plasma (TG/HDLc), ApoA-1 Apolipoprotein A-1, ApoB Apolipoprotein B, GS Gensini score, HbA1c Gyrated hemoglobin, Hcy Homocysteine, HDL-c High density lipoprotein cholesterol, HGB Hemoglobin, Hs-CRP High sensitivity C-reactive protein, IL-6 Interleukin 6, LDL-c Low density lipoprotein cholesterol, Lp(a) Lipoprotein(a), TC Total cholesterol, TG Triglycerides. Values are expressed as the mean ± SD. ACE Angiotensin converting enzyme inhibitor, DBP Diastolic blood pressure, LAD Left anterior descending, LCx Left circumflex, LDL-c Low density lipoprotein cholesterol, LMCA Left main coronary artery, LVEF Left ventricular ejection fraction, RCA Right coronary artery, SBP Systolic blood pressure. Values are expressed as the mean ± SD or n (%). p < 0.05. p < 0.05